METTL3-dependent DLG2 inhibits the malignant progression of cervical cancer by inactivating the Hippo/YAP signaling

Abstract Background Discs large homolog 2 (DLG2) has been implicated in cancer development, yet its role in cervical cancer remains unclear. This study aims to explore the regulatory mechanism of DLG2 in cervical cancer and its clinical implications. Methods Quantitative reverse transcription polyme...

Full description

Saved in:
Bibliographic Details
Main Authors: Mei Pu, Xia Xiao, Shasha Lv, Daqing Ran, Qian Huang, Mingming Zhou, Qirong Lei, Lingshuang Kong, Qing Zhang
Format: Article
Language:English
Published: BMC 2025-01-01
Series:Hereditas
Subjects:
Online Access:https://doi.org/10.1186/s41065-025-00365-z
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832585635117924352
author Mei Pu
Xia Xiao
Shasha Lv
Daqing Ran
Qian Huang
Mingming Zhou
Qirong Lei
Lingshuang Kong
Qing Zhang
author_facet Mei Pu
Xia Xiao
Shasha Lv
Daqing Ran
Qian Huang
Mingming Zhou
Qirong Lei
Lingshuang Kong
Qing Zhang
author_sort Mei Pu
collection DOAJ
description Abstract Background Discs large homolog 2 (DLG2) has been implicated in cancer development, yet its role in cervical cancer remains unclear. This study aims to explore the regulatory mechanism of DLG2 in cervical cancer and its clinical implications. Methods Quantitative reverse transcription polymerase chain reaction and western blotting assays were employed to detect RNA and protein expression, respectively. Colony formation assay, 5-Ethynyl-2’-deoxyuridine assay, flow cytometry, and transwell assays were conducted for cell functional analysis. A xenograft mouse model assay was performed to analyze tumor tumorigenesis in vivo. m6A RNA immunoprecipitation assay was used to analyze the association of METTL3 and DLG2. Results DLG2 was underexpressed in cervical cancer tissues and cells. Elevating DLG2 levels significantly suppressed cervical cancer cell proliferation, migration, and invasion, while promoting apoptosis. Additionally, DLG2 overexpression led to the deactivation of the Hippo/YAP signaling pathway. In vivo, DLG2 overexpression was shown to reduce tumor formation. We also discovered that METTL3 destabilized DLG2 mRNA through an m6A-dependent mechanism. Moreover, lowering DLG2 expression mitigated the effects of METTL3 silencing on cervical cancer cell malignancy. Conclusion DLG2 acted as a tumor suppressor in cervical cancer by inhibiting the Hippo/YAP signaling pathway. The METTL3-dependent regulation of DLG2 mRNA stability could be a critical factor in cervical cancer progression.
format Article
id doaj-art-584800fd3ccf4f2495b5a49eab97e9f9
institution Kabale University
issn 1601-5223
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series Hereditas
spelling doaj-art-584800fd3ccf4f2495b5a49eab97e9f92025-01-26T12:36:39ZengBMCHereditas1601-52232025-01-01162111210.1186/s41065-025-00365-zMETTL3-dependent DLG2 inhibits the malignant progression of cervical cancer by inactivating the Hippo/YAP signalingMei Pu0Xia Xiao1Shasha Lv2Daqing Ran3Qian Huang4Mingming Zhou5Qirong Lei6Lingshuang Kong7Qing Zhang8Department of Obstetrics and Gynecology, Dazhou Vocational and Technical CollegeChongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer HospitalDepartment of Obstetrics and Gynecology, Dazhou Vocational and Technical CollegeDepartment of Obstetrics and Gynecology, Dazhou Vocational and Technical CollegeDepartment of Obstetrics and Gynecology, Dazhou Vocational and Technical CollegeChongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer HospitalDepartment of Dermatology, The Affiliated Hospital of Southwest Medical UniversityChongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer HospitalDepartment of Dermatology, The Affiliated Hospital of Southwest Medical UniversityAbstract Background Discs large homolog 2 (DLG2) has been implicated in cancer development, yet its role in cervical cancer remains unclear. This study aims to explore the regulatory mechanism of DLG2 in cervical cancer and its clinical implications. Methods Quantitative reverse transcription polymerase chain reaction and western blotting assays were employed to detect RNA and protein expression, respectively. Colony formation assay, 5-Ethynyl-2’-deoxyuridine assay, flow cytometry, and transwell assays were conducted for cell functional analysis. A xenograft mouse model assay was performed to analyze tumor tumorigenesis in vivo. m6A RNA immunoprecipitation assay was used to analyze the association of METTL3 and DLG2. Results DLG2 was underexpressed in cervical cancer tissues and cells. Elevating DLG2 levels significantly suppressed cervical cancer cell proliferation, migration, and invasion, while promoting apoptosis. Additionally, DLG2 overexpression led to the deactivation of the Hippo/YAP signaling pathway. In vivo, DLG2 overexpression was shown to reduce tumor formation. We also discovered that METTL3 destabilized DLG2 mRNA through an m6A-dependent mechanism. Moreover, lowering DLG2 expression mitigated the effects of METTL3 silencing on cervical cancer cell malignancy. Conclusion DLG2 acted as a tumor suppressor in cervical cancer by inhibiting the Hippo/YAP signaling pathway. The METTL3-dependent regulation of DLG2 mRNA stability could be a critical factor in cervical cancer progression.https://doi.org/10.1186/s41065-025-00365-zCervical cancerDLG2METTL3Hippo/YAP signaling pathway
spellingShingle Mei Pu
Xia Xiao
Shasha Lv
Daqing Ran
Qian Huang
Mingming Zhou
Qirong Lei
Lingshuang Kong
Qing Zhang
METTL3-dependent DLG2 inhibits the malignant progression of cervical cancer by inactivating the Hippo/YAP signaling
Hereditas
Cervical cancer
DLG2
METTL3
Hippo/YAP signaling pathway
title METTL3-dependent DLG2 inhibits the malignant progression of cervical cancer by inactivating the Hippo/YAP signaling
title_full METTL3-dependent DLG2 inhibits the malignant progression of cervical cancer by inactivating the Hippo/YAP signaling
title_fullStr METTL3-dependent DLG2 inhibits the malignant progression of cervical cancer by inactivating the Hippo/YAP signaling
title_full_unstemmed METTL3-dependent DLG2 inhibits the malignant progression of cervical cancer by inactivating the Hippo/YAP signaling
title_short METTL3-dependent DLG2 inhibits the malignant progression of cervical cancer by inactivating the Hippo/YAP signaling
title_sort mettl3 dependent dlg2 inhibits the malignant progression of cervical cancer by inactivating the hippo yap signaling
topic Cervical cancer
DLG2
METTL3
Hippo/YAP signaling pathway
url https://doi.org/10.1186/s41065-025-00365-z
work_keys_str_mv AT meipu mettl3dependentdlg2inhibitsthemalignantprogressionofcervicalcancerbyinactivatingthehippoyapsignaling
AT xiaxiao mettl3dependentdlg2inhibitsthemalignantprogressionofcervicalcancerbyinactivatingthehippoyapsignaling
AT shashalv mettl3dependentdlg2inhibitsthemalignantprogressionofcervicalcancerbyinactivatingthehippoyapsignaling
AT daqingran mettl3dependentdlg2inhibitsthemalignantprogressionofcervicalcancerbyinactivatingthehippoyapsignaling
AT qianhuang mettl3dependentdlg2inhibitsthemalignantprogressionofcervicalcancerbyinactivatingthehippoyapsignaling
AT mingmingzhou mettl3dependentdlg2inhibitsthemalignantprogressionofcervicalcancerbyinactivatingthehippoyapsignaling
AT qironglei mettl3dependentdlg2inhibitsthemalignantprogressionofcervicalcancerbyinactivatingthehippoyapsignaling
AT lingshuangkong mettl3dependentdlg2inhibitsthemalignantprogressionofcervicalcancerbyinactivatingthehippoyapsignaling
AT qingzhang mettl3dependentdlg2inhibitsthemalignantprogressionofcervicalcancerbyinactivatingthehippoyapsignaling